Details for Patent: RE47739
✉ Email this page to a colleague
Which drugs does patent RE47739 protect, and when does it expire?
Patent RE47739 protects IBRANCE and is included in two NDAs.
This patent has seventy-three patent family members in forty-nine countries.
Summary for Patent: RE47739
| Title: | 2-(pyridin-2-ylamino)-pyrido[2,3-D]pyrimidin-7-ones |
| Abstract: | The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4) ##STR00001## |
| Inventor(s): | Barvian; Mark (Ann Arbor, MI), Booth; Richard John (Ann Arbor, MI), Quinn, III; John (Ann Arbor, MI), Repine; Joseph Thomas (Ann Arbor, MI), Sheehan; Derek J. (Dexter, MI), Toogood; Peter Lawrence (Ann Arbor, MI), Vanderwel; Scott Norman (Ann Arbor, MI), Zhou; Hairong (Ann Arbor, MI) |
| Assignee: | Warner-Lambert Company LLC (New York, NY) |
| Application Number: | 16/048,143 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent RE47739
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | IBRANCE | palbociclib | CAPSULE;ORAL | 207103-001 | Feb 3, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Pfizer | IBRANCE | palbociclib | CAPSULE;ORAL | 207103-002 | Feb 3, 2015 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Pfizer | IBRANCE | palbociclib | CAPSULE;ORAL | 207103-003 | Feb 3, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE47739
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1470124 | ⤷ Sign Up | 300863 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1470124 | ⤷ Sign Up | 122017000014 | Germany | ⤷ Sign Up |
| European Patent Office | 1470124 | ⤷ Sign Up | PA2017013 | Lithuania | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
